Big news in the world of programmable mRNA therapy! We received FDA IND clearance for STX-001, our programmable #
mRNA# therapy to treat solid tumors. Phase 1 trials are now underway. #
mRNA# #
ClinicalTrials# #
Oncology# #
ProgrammableMedicines#
Read our release: